Margaret Mueller to Mice
This is a "connection" page, showing publications Margaret Mueller has written about Mice.
Connection Strength
0.432
-
Effects of selective MMP-13 inhibition in squamous cell carcinoma depend on estrogen. Int J Cancer. 2014 Dec 15; 135(12):2749-59.
Score: 0.044
-
Cell type specific interleukin-6 induced responses in tumor keratinocytes and stromal fibroblasts are essential for invasive growth. Int J Cancer. 2014 Aug 01; 135(3):551-62.
Score: 0.043
-
GM-CSF enhances tumor invasion by elevated MMP-2, -9, and -26 expression. Cancer Med. 2013 Apr; 2(2):117-29.
Score: 0.039
-
Integrating macrophages into organotypic co-cultures: a 3D in vitro model to study tumor-associated macrophages. PLoS One. 2012; 7(7):e40058.
Score: 0.038
-
Vascular endothelial growth factor-induced skin carcinogenesis depends on recruitment and alternative activation of macrophages. J Pathol. 2012 May; 227(1):17-28.
Score: 0.037
-
Platelet-derived growth factor-B normalizes micromorphology and vessel function in vascular endothelial growth factor-A-induced squamous cell carcinomas. Am J Pathol. 2010 Feb; 176(2):981-94.
Score: 0.032
-
Distinct progression-associated expression of tumor and stromal MMPs in HaCaT skin SCCs correlates with onset of invasion. Int J Cancer. 2009 Nov 15; 125(10):2296-306.
Score: 0.032
-
MMP13 as a stromal mediator in controlling persistent angiogenesis in skin carcinoma. Carcinogenesis. 2010 Jul; 31(7):1175-84.
Score: 0.031
-
Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor promote malignant growth of cells from head and neck squamous cell carcinomas in vivo. Cancer Res. 2006 Aug 15; 66(16):8026-36.
Score: 0.025
-
Cooperative autocrine and paracrine functions of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the progression of skin carcinoma cells. Cancer Res. 2004 Nov 01; 64(21):7801-12.
Score: 0.022
-
Tumor-stroma interactions directing phenotype and progression of epithelial skin tumor cells. Differentiation. 2002 Dec; 70(9-10):486-97.
Score: 0.019
-
MMP inhibition blocks fibroblast-dependent skin cancer invasion, reduces vascularization and alters VEGF-A and PDGF-BB expression. Anticancer Res. 2010 Mar; 30(3):703-11.
Score: 0.008
-
RGD-labeled USPIO inhibits adhesion and endocytotic activity of alpha v beta3-integrin-expressing glioma cells and only accumulates in the vascular tumor compartment. Radiology. 2009 Nov; 253(2):462-9.
Score: 0.008
-
Molecular profiling of angiogenesis with targeted ultrasound imaging: early assessment of antiangiogenic therapy effects. Mol Cancer Ther. 2008 Jan; 7(1):101-9.
Score: 0.007
-
Volumetric high-frequency Doppler ultrasound enables the assessment of early antiangiogenic therapy effects on tumor xenografts in nude mice. Eur Radiol. 2008 Apr; 18(4):753-8.
Score: 0.007
-
Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner. Cancer Res. 2007 Feb 15; 67(4):1555-62.
Score: 0.007
-
Reversion of tumor phenotype in surface transplants of skin SCC cells by scaffold-induced stroma modulation. Carcinogenesis. 2007 Mar; 28(3):595-610.
Score: 0.006
-
Potential applications of flat-panel volumetric CT in morphologic and functional small animal imaging. Neoplasia. 2005 Aug; 7(8):730-40.
Score: 0.006
-
Angiogenesis inhibition by vascular endothelial growth factor receptor-2 blockade reduces stromal matrix metalloproteinase expression, normalizes stromal tissue, and reverts epithelial tumor phenotype in surface heterotransplants. Cancer Res. 2005 Feb 15; 65(4):1294-305.
Score: 0.006
-
Volumetric computed tomography (VCT): a new technology for noninvasive, high-resolution monitoring of tumor angiogenesis. Nat Med. 2004 Oct; 10(10):1133-8.
Score: 0.005
-
Dynamic contrast-enhanced magnetic resonance imaging rapidly indicates vessel regression in human squamous cell carcinomas grown in nude mice caused by VEGF receptor 2 blockade with DC101. Neoplasia. 2004 May-Jun; 6(3):213-23.
Score: 0.005
-
Sensitive noninvasive monitoring of tumor perfusion during antiangiogenic therapy by intermittent bolus-contrast power Doppler sonography. Cancer Res. 2003 Dec 01; 63(23):8264-70.
Score: 0.005